Fecal material transplantation (FMT) has been shown effective in improving the overall response to PD-1 therapy in patients with melanoma or epithelial tumors, which indicates a substantial role of gut microbiota in modulating host immune response following PD-1 treatment (48, 49). The gene discussed is PDCD1; the disease is melanoma.